Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Heterologous Fecal microbiotA Transfer in ICU Patients: a FeasibilitY and SafetY StudY

NCT03350178 is registered in ClinicalTrials.gov with MaaT Pharma as lead sponsor.

NCT NCT03350178
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03350178 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Heterologous Fecal microbiotA Transfer in ICU Patients: a FeasibilitY and SafetY StudY
Lead sponsor
MaaT Pharma
Phase
Phase 2
Overall status
Terminated
Start date
January 15, 2018
Completion date
February 19, 2019
Enrollment
8 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

fecal microbiota transplantation, intensive care units